New Delhi: FSSAI has issued notices over growth and immunity claims used to market Complan and infant-nutrition products, and over an Instagram reel promoting infant milk substitutes. The action includes notices to Zydus Wellness Products Limited, Nestlé India Limited, an Instagram creator and other infant-formula companies.
The Food Safety and Standards Authority of India has sought scientific evidence for specific product claims and explanations on why regulatory action should not follow. Its notice summaries cover Complan, Lactogen Pro 1 Powder, Nan Excella Pro Stage 1 and a reel recommending five infant-formula products.
FSSAI has issued notices to Food Business Operators (FBOs) regarding misleading claims and non-compliant promotions involving products like Complan, Lactogen Pro 1 Powder, Nan Excella Pro Stage 1 and infant milk substitutes.
#FSSAINotice #FSSAIAction
— FSSAI (@fssaiindia) October 21, 2026
Complan growth and immunity claims questioned
In its notice to Zydus Wellness Products Limited, FSSAI said Complan’s label and online listing featured two children alongside claims of faster growth, support for concentration and memory, and immunity benefits linked to 34 nutrients.
The regulator said the claims violated the Food Safety and Standards (Advertising and Claims) Regulations, 2018. It sought scientific justification for claims of clinically demonstrated doubled growth and the stated immunity benefits.
FSSAI also objected to an advertisement linking growth to the product’s four flavours. The company was directed to explain, within the stipulated period, why action should not be initiated under the Food Safety and Standards Act, 2006, and the rules and regulations made under it.
Nestlé asked to substantiate infant-formula claims
A separate notice to Nestlé India concerned Lactogen Pro 1 Powder. FSSAI said packaging or advertising material carried a claim presenting whey protein, a component of milk protein, as easy to digest.
The company was asked to provide scientific substantiation and supporting documents within the stipulated period.
For Nan Excella Pro Stage 1, FSSAI questioned a claim linking five HMOs to support for a normal immune system. The regulator said the wording suggested suitability in relation to a particular physiological condition.
It considered that claim non-compliant with provisions restricting claims about preventing, alleviating, treating or curing a disease, disorder or particular physiological condition unless specifically permitted under the applicable regulations.
FSSAI also sought scientific support for the product’s whey-protein digestion claim. Nestlé was directed to explain why action should not be initiated under the food-safety law and its rules and regulations within the stipulated period.
Instagram infant-formula promotion draws notices
The regulator also issued notices to Ira Fathima, Abbott Healthcare Pvt. Ltd., Nestlé India Limited, Nutricia International Private Limited and Mead Johnson Nutrition (India) Pvt. Ltd. concerning the advertising and promotion of infant milk substitutes through Instagram.
According to FSSAI, a reel posted by Fathima contained a ranked selection of five infant-formula products: Nan-Pro 1, Aptamil Premium 1, Similac Advance 1, Enfamil A+ Stage 1 and Dexolac 1.
The promotional content attributed benefits including balanced nutrition, stronger immunity, brain development and easier digestion to the products, the regulator said.
FSSAI alleged that the promotion contravened the Infant Milk Substitutes Act, 1992, as amended in 2003, and advertising, marketing and promotion requirements under the Food Safety and Standards (Foods for Infant Nutrition) Regulations, 2020.
The addressees were directed to explain why action should not be initiated under the Food Safety and Standards Act, 2006, and its rules and regulations within the stipulated period from issuance of the notice.
This report will be updated once a response is received from the companies named in the FSSAI notices.
Related coverage: FSSAI sanctions proceedings against Storia over pomegranate juice label claims.
